Publications

Filter results by

List of Publications

Title Date PC3I Authors Journal
Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy June 15, 2022
PC3I Authors
Charu Aggarwal
Scientific Reports
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19 June 15, 2022
PC3I Authors
Alix Seif; Allison Barz Leahy; Haley Newman
Clinical Cancer Research
Rural-urban disparities in place of death in hematologic malignancies in the United States, 2003 to 2019 June 15, 2022
PC3I Authors
Ramy Sedhom
Blood Advances
Effect of Text Messaging and Behavioral Interventions on COVID-19 Vaccination Uptake: A Randomized Clinical Trial June 13, 2022
PC3I Authors
Shivan Mehta
JAMA Network Open
Trajectories of Pain Severity and Interference Among Adolescent and Young Adults With Cancer: A Microlongitudinal Study June 10, 2022
PC3I Authors
Lisa A. Schwartz
The Clinical Journal of Pain
Reliability and Validity Testing of the Caregiver-Centered Communication Questionnaire June 9, 2022
PC3I Authors
George Demiris
Journal of Nursing Measurement
Aumolertinib in EGFR-Mutant Lung Cancer: Will the Promise of Cost Disruption Ease Access? June 9, 2022
PC3I Authors
Charu Aggarwal
Journal of Clinical Oncology
Association of the Affordable Care Act’s Medicaid Expansion With 1-Year Survival Among Patients With Ovarian Cancer June 8, 2022
PC3I Authors
Anna Jo Smith
Obstetrics and Gynecology
Real-World Adherence to Patient-Reported Outcome Monitoring as a Cancer Care Quality Metric June 8, 2022
PC3I Authors
Samuel Takvorian; Peter Gabriel; Larry Shulman
JCO Oncology Practice
Using Informatics to Engage Vulnerable Populations in Research: Lessons Learned from the COVID-19 Pandemic June 8, 2022
PC3I Authors
George Demiris
Studies in Health Technology and Informatics
Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practice June 7, 2022
PC3I Authors
Ronac Mamtani; Melina Marmarelis
Pharmacoepidemiology and Drug Safety
Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database June 6, 2022
PC3I Authors
Emily Ko
Gynecologic Oncology
Guideline discordant care in patients with metastatic germ cell tumors June 6, 2022
PC3I Authors
Larry Shulman
Urologic Oncology
Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma June 2, 2022
PC3I Authors
Ronac Mamtani
Journal of Cancer Research and Clinical Oncology
Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis June 2, 2022
PC3I Authors
Anne Marie McCarthy
Cancer Medicine
Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion June 1, 2022
PC3I Authors
Emily Ko
International Journal of Gynecological Cancer
Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine June 1, 2022
PC3I Authors
Larry Shulman
JCO Global Oncology
Patient perspectives on delays in cervical cancer screening and follow-up care in Botswana: a mixed methods study June 1, 2022
PC3I Authors
Katharine Rendle; Jocelyn Wainwright; Hannah Toneff; Surbhi Grover
BMC Women's Health
Digital Health Applications in Oncology: An Opportunity to Seize May 31, 2022
PC3I Authors
Larry Shulman
Journal of the National Cancer Institute
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma May 31, 2022
PC3I Authors
Charu Aggarwal
Journal for Immunotherapy of Cancer